中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
33期
318-319
,共2页
黄蕾%陈诚%吴俚蓉%吴建峰
黃蕾%陳誠%吳俚蓉%吳建峰
황뢰%진성%오리용%오건봉
高级别胶质瘤%调强放疗%替莫唑胺
高級彆膠質瘤%調彊放療%替莫唑胺
고급별효질류%조강방료%체막서알
High-grade glioma%Intensity modulated radiotherapy%Temozolomide
目的:观察替莫唑胺联合调强放疗治疗高级别胶质瘤的近期临床疗效,评估治疗的安全性。方法对48例高级别脑胶质瘤术后患者进行回顾性研究,分为对照组(n=25)、联合治疗组(n=24)。对照组患者术后行调强放疗,总剂量60Gy;联合治疗组患者行调强放疗的同时口服替莫唑胺75mg/(m2?d)。两组患者治疗过程中每周监测血常规、肝功能及肾功能。结果49例高级别脑胶质瘤术后患者放化疗结束后随访12个月,联合治疗组的总有效率为79.17%(19/24),对照组的总有效率为41.67%(10/24),两组比较,差异有统计学意义(P<0.05)。联合治疗组患者不良反应较对照组多见,但经对症治疗,可获得缓解,患者能耐受。结论替莫唑胺联合调强放疗治疗术后高级别胶质瘤脑胶质瘤具有协同效应,提高治疗效果,安全可靠。
目的:觀察替莫唑胺聯閤調彊放療治療高級彆膠質瘤的近期臨床療效,評估治療的安全性。方法對48例高級彆腦膠質瘤術後患者進行迴顧性研究,分為對照組(n=25)、聯閤治療組(n=24)。對照組患者術後行調彊放療,總劑量60Gy;聯閤治療組患者行調彊放療的同時口服替莫唑胺75mg/(m2?d)。兩組患者治療過程中每週鑑測血常規、肝功能及腎功能。結果49例高級彆腦膠質瘤術後患者放化療結束後隨訪12箇月,聯閤治療組的總有效率為79.17%(19/24),對照組的總有效率為41.67%(10/24),兩組比較,差異有統計學意義(P<0.05)。聯閤治療組患者不良反應較對照組多見,但經對癥治療,可穫得緩解,患者能耐受。結論替莫唑胺聯閤調彊放療治療術後高級彆膠質瘤腦膠質瘤具有協同效應,提高治療效果,安全可靠。
목적:관찰체막서알연합조강방료치료고급별효질류적근기림상료효,평고치료적안전성。방법대48례고급별뇌효질류술후환자진행회고성연구,분위대조조(n=25)、연합치료조(n=24)。대조조환자술후행조강방료,총제량60Gy;연합치료조환자행조강방료적동시구복체막서알75mg/(m2?d)。량조환자치료과정중매주감측혈상규、간공능급신공능。결과49례고급별뇌효질류술후환자방화료결속후수방12개월,연합치료조적총유효솔위79.17%(19/24),대조조적총유효솔위41.67%(10/24),량조비교,차이유통계학의의(P<0.05)。연합치료조환자불량반응교대조조다견,단경대증치료,가획득완해,환자능내수。결론체막서알연합조강방료치료술후고급별효질류뇌효질류구유협동효응,제고치료효과,안전가고。
Objective To investigate the short-term clinical efifcacy and safety of postoperative radiotherapy combined with temozolomide chemotherapy in treating high-grade gliomas. Methods Forty-eight patients with high-grade gliomas who had accepted resection were divided into two groups:control group(n=24)and combination treatment group(n=24). Both groups were given intensity modulated radiotherapy with total dose of 60 Gy and the control group was given additional Temozolomide chemotherapy.The complete blood count,hepatic and renal function of all patients in both group were monitored. Results The total effective rate in the combination treatment group was 79.17%(19/24),which was 41.67%(10/24)in the control group.The total effective rates were significantly different between the two groups(P<0.05).There were more adverse reactions in the combination treatment group than in the control group. Adverse effects could be relieved after symptomatic treatment. Conclusion Intensity modulated radiotherapy combined with Temozolomide chemotherapy for high-grade gliomas can improve curative effects,is safe and reliable.